Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 9, Number 8, August 2017, pages 701-708


Autologous Stromal Vascular Fraction in the Intravenous Treatment of End-Stage Chronic Obstructive Pulmonary Disease: A Phase I Trial of Safety and Tolerability

Tables

Table 1. Study Participant Demographics
 
AgeSexMethod of searchLocal physician input on study participationSmoking (PYH)Infusion side effectsPre ASC oxygenHospitalizations pre ASC
PYH: per year history; ASCs: adipose stem cells; ER: emergency room.
72MInternetPulmonologist: indifferent40None31 hospital, ER 6 - 8 wks prior
MInternetPulmonologist: supportive100None31
FInternetPhysicians indifferent75None2Monthly
FInternetInternist: supportive; pulmonologist: recommended against70None2Bi-yearly
70MInternetPulmonologist: indifferent50Liposuction painful, IV infiltration: new IV started01 ER
61FInternetInternist: supportive; pulmonologist/cardiologist against40None2No
73FInternetPulmonologist: recommended against45None2No
FInternetPhysician indifferent50None21 ER
69MInternetDid not consult with physician60None21 ER
57FInternetKaiser physician was “insulted” that patient would consider non-approved therapy20None2Yes
63MInternetPulmonologist: doubtful of approach but did not advise against participation90Liposuction painful3Yes
MAnother study participantInternist: against approachLittle but welder so environmental exposureNone2.5No

 

Table 2. Study Participant Perceptions of Treatment Effect, Time to Maximal Effect, Loss of Effect, Perspectives on Re-Infusion, and Undirected Comments
 
AgeSexSmoking (PY)Time post-infusion at independent interview (months)Time to optimal subjective effectTime course of overall effectWaning of effect over timeDo it again?Other comments and effects noted (undirected)
PY: packs per year; UTI: urinary track infection; RLL: right lower lobe; SOB: shortness of breath.
72M40131 dayContinually getting betterNoYesLethargy, memory loss, pallor gone, arthritis gone for 2 months, actinic keratosis better, increased sex drive, better hearing, exercises
M100171 monthContinually getting betterNoYesSounds and looks better
F751 monthContinually getting betterNoYesOff prednisone
F701 month3 monthsYesNo (yes if cost-free)Looks better, no cough, no bronchitis
70M5023NoneNoneYesNo (yes if cost-free)Getting worse
61F40151 monthContinually getting betterNoNo (yes if cost-free)Feels stronger and does not get URIs, but not oxygen-independent which is what was hoped for
73F4512NoneNoneYesYesThyroid is better; pulmonologist decreasing thyroid meds
F50271 day3 monthsYesYes15-20% increase in breathing capabilities initially, now baseline; RLL malignancy discovered after treatment; cough better since treatment
69M60201 monthGradually getting worse after first monthYesNo (yes if cost-free)Easier oxygen intake, but no difference
57F20 (quit 2009)instantly1 monthNoYesAlso had similar infusions (3) at another (US) facility. Noted that fatigue lessened and post-exertional recovery improved.
63M907NoneNoneNoneNoOn UCLA lung transplant program
MLittle but welder so environmental exposure181 dayContinually getting betterNoYes, if he could receive without travelFewer panic attacks due to SOB, wife noticed patient has been less confused and has had fewer other medical issues; still on oxygen